Literature DB >> 22469323

Sunitinib malate.

Mohammed Gabr Kassem1, A F M Motiur Rahman, Hesham M Korashy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22469323     DOI： 10.1016/B978-0-12-397220-0.00009-X

Source DB:  PubMed          Journal:  Profiles Drug Subst Excip Relat Methodol        ISSN： 1871-5125


× No keyword cloud information.
  3 in total

1.  Synthesis of sericin-based conjugates by click chemistry: enhancement of sunitinib bioavailability and cell membrane permeation.

Authors:  Luca Scrivano; Domenico Iacopetta; Maria Stefania Sinicropi; Carmela Saturnino; Pasquale Longo; Ortensia Ilaria Parisi; Francesco Puoci
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

2.  Relationship between efficacy of sunitinib and KIT mutation of patients with advanced gastrointestinal stromal tumors after failure of imatinib: A systematic review.

Authors:  Fuming Xie; Weidong Xiao; Yahui Jiang; Xiao Xia; Yaxu Wang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

3.  Dasatinib/HP-β-CD Inclusion Complex Based Aqueous Formulation as a Promising Tool for the Treatment of Paediatric Neuromuscular Disorders.

Authors:  Annalisa Cutrignelli; Francesca Sanarica; Antonio Lopalco; Angela Lopedota; Valentino Laquintana; Massimo Franco; Brigida Boccanegra; Paola Mantuano; Annamaria De Luca; Nunzio Denora
Journal:  Int J Mol Sci       Date:  2019-01-30       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.